Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Advances in Congestion Assessment in Decompensated Heart Failure
Author(s): Archana Ganapathy , Jason N Dungu , Anthony D Dimarco , et al Added: 4 months ago

Heart Failure
Author(s): Julian Gillmore , Margot K Davis , Ahmad Masri , et al Added: 1 year ago
First presented at ESC 2024, this on-demand programme sees Prof Julian Gillmore (University College London, London, UK) lead a distinguished faculty compromising of Dr Ahmad Masri (Oregon Health & Science University Medical Group, Portland, US), Dr Margot Davis (University of British Columbia, Vancouver, CA), and Dr Giuseppe Vergaro (Sant’Anna, Pisa, IT).The faculty present recent epidemiological… View more

Heart Failure
Miel Dabush
Healthcare IT Manager, Assuta Medical Center, Israel View more
Device-Based Strategies for Guideline-Directed Therapy in Heart Failure
Author(s): Renzo Laborante , Attilio Restivo , Daniela Mele , et al Added: 1 year ago

Prevention & Chronic Conditions

Heart Failure
What’s Hot at ACC.26: Preview with Dr Latib & Prof Van Mieghem
Author(s): Nicolas M Van Mieghem , Azeem Latib Added: 3 months ago
What’s Hot at ACC.26: in this focused preview, Dr Azeem Latib (Montefiore Medical Center, US) and Prof Nicolas Van Mieghem, MD, PhD, pick out the late‑breaking clinical trials at ACC.26 that are most likely to influence practice for operators heading to New Orleans. In a fast, conversational format, they move from pulmonary embolism and left atrial appendage closure to heart failure, STEMI… View more

Imaging & Diagnostics

Intervention
Heart Failure 2024
Author(s): Harriette Van Spall , Mark Petrie Added: 2 years ago
Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Association’s annual congress, Heart Failure 2024.Dive deep into novel data with in-depth and critical discussions led by Late-breaker host Dr Harriette Van Spall and her expert guests.For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted… View more

Heart Failure
Jeffrey J Goldberger
Personal History Jeffrey J Goldberger is based in Miami, Florida where he works as Professor of Medicine, Director of Cardiac Electrophysiology Research and Director of the Program in Cardiac Arrhythmias for the Center for Cardiovascular Innovation. He is a father of four and has one grandchild.4 Academic History Jeffrey Goldberger, M.D., M.B.A., received his Bachelor of Science… View more
Job title: Managing Editor, Cardiac Failure Review and Interventional Cardiology Review
To contact the managing editor, emailagnieszka.topolska@radcliffe-group.com. View more
ACC 26: SURPASS-CVOT - Tirzepatide vs Dulaglutide in T2D
Author(s): Steven E Nissen Added: 2 months ago
American College of Cardiology Congress 2026 – Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the effects of tirzepatide compared with dulaglutide on expanded cardiorenal outcomes from the SURPASS-CVOT trial (NCT04255433; Eli Lilly and Company).This international, double-blind, randomised, phase III cardiovascular outcomes trial enrolled 13,299 patients aged 40 and… View more

Cardiovascular Kidney Metabolic

Heart Failure
ESC 25 Hot Line Discussion: DIGIT-HF: Cardiac Glycosides in HFrEF
Author(s): Harriette Van Spall , Udo Bavendiek Added: 9 months ago
ESC Congress 2025 - Digitoxin reduced the risk of all-cause mortality and hospitalisation in patients with worsening heart failure.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Udo Bavendiek to explore the DIGIT-HF trial, investigating whether digitoxin can improve outcomes in patients with advanced chronic heart failure and reduced ejection fraction.This landmark study… View more

Prevention & Chronic Conditions

Heart Failure